Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
5.22
0.00 (0.00%)
At close: Mar 6, 2026, 4:00 PM EST
5.35
+0.13 (2.49%)
After-hours: Mar 6, 2026, 7:59 PM EST
Larimar Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 18.68 | 18.11 | 14.49 | 12.28 | 12.07 | 11.4 | |
| Research & Development | 121.09 | 72.78 | 27.27 | 24.25 | 38.4 | 31.41 | |
| Operating Expenses | 139.77 | 90.89 | 41.76 | 36.53 | 50.47 | 42.8 | |
| Operating Income | -139.77 | -90.89 | -41.76 | -36.53 | -50.47 | -42.8 | |
| Other Non Operating Income (Expenses) | 7.77 | 10.29 | 4.81 | 1.17 | -0.17 | 0.32 | |
| Pretax Income | -132 | -80.6 | -36.95 | -35.36 | -50.64 | -42.48 | |
| Net Income | -132 | -80.6 | -36.95 | -35.36 | -50.64 | -42.48 | |
| Net Income to Common | -132 | -80.6 | -36.95 | -35.36 | -50.64 | -42.48 | |
| Shares Outstanding (Basic) | 68 | 61 | 44 | 26 | 17 | 12 | |
| Shares Outstanding (Diluted) | 68 | 61 | 44 | 26 | 17 | 12 | |
| Shares Change (YoY) | 20.08% | 39.53% | 70.42% | 50.09% | 44.44% | 95.09% | |
| EPS (Basic) | -1.95 | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 | |
| EPS (Diluted) | -1.95 | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 | |
| Free Cash Flow | -96.76 | -71.28 | -33.62 | -27.67 | -42.44 | -42.26 | |
| Free Cash Flow Per Share | -1.43 | -1.16 | -0.77 | -1.07 | -2.47 | -3.56 | |
| EBITDA | -139.43 | -90.57 | -41.45 | -36.21 | -50.14 | -42.65 | |
| D&A For EBITDA | 0.34 | 0.32 | 0.31 | 0.32 | 0.33 | 0.16 | |
| EBIT | -139.77 | -90.89 | -41.76 | -36.53 | -50.47 | -42.8 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.